REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/08/2025
Back to search
Official data from USPTO
DREAMED DIABETES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DREAMED DIABETES
ST13
US500000079267062Class
9, 10, 44
Filing
79267062
Registration
6144170
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
09/09/2025
Trademark type
Word
Nice classes
9, 10, 44
Filing date
06/17/2019
Registration date
09/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/08/2020
Last transaction
09/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
IL
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DreaMed Diabetes LTD.
Representatives
Alex Patel Patel & Almeida PC
Technical classification
Nice Classes
Class 9Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable mobile application and recorded computer software for analysis of medical information in the field of diabetes via the internet
Class 10
Wearable medical apparatus for the monitoring and compilation of biometric medical information in the field of diabetes; medical apparatus inserted into the human body for the monitoring and compilation of biometric medical information in the field of diabetes; medical diagnostic apparatus for the compilation of medical information and medical specimens from patients in the field of diabetes
Class 44
Medical analysis for the treatment of persons; providing information in the field of medicine; providing information to patients in the field of administering medication; medical consultancy; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical care and analysis services relating to patient treatment; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; advisory services relating to healthcare; advisory services relating to health
Publications
History of USPTO decisions and trademark events.
45 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/22/2020
FIMP
FINAL DISPOSITION PROCESSED
12/22/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/19/2020
RFNP
REFUSAL PROCESSED BY IB
06/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/20/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/20/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/20/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/11/2020
GNRT
NON-FINAL ACTION E-MAILED
05/11/2020
CNRT
NON-FINAL ACTION WRITTEN
05/11/2020
DOCK
ASSIGNED TO EXAMINER
04/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2020
ALIE
ASSIGNED TO LIE
04/17/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/13/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/10/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/10/2019
CNSL
SUSPENSION LETTER WRITTEN
12/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2019
RFNT
REFUSAL PROCESSED BY IB
10/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2019
RFRR
REFUSAL PROCESSED BY MPU
09/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/18/2019
CNRT
NON-FINAL ACTION WRITTEN
09/17/2019
DOCK
ASSIGNED TO EXAMINER
09/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/12/2019
Continuous trademark protection
Get notified about every new filing that threatens DREAMED DIABETES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.